KIR3DS1 is an activating killer cell immunoglobulin-like receptor expressed on natural killer (NK) cells that mediates immune responses against viral infections and transformed cells. KIR3DS1 functions as a pattern recognition receptor that engages HLA class I molecules displaying specific peptide motifs, triggering NK cell activation and effector functions 1. The primary ligand for KIR3DS1 is HLA-F in its open conformer state 2, though peptide-dependent recognition of HLA-B allotypes carrying the Bw4 motif also occurs 31. Upon ligand engagement, KIR3DS1 stimulation induces NK cell degranulation and interferon-gamma production 4. Clinically, KIR3DS1 expression associates with improved outcomes in viral infections. In HIV-1 infection, individuals carrying KIR3DS1 combined with HLA-Bw4-I80 show slower disease progression to AIDS 4. Similarly, pediatric allogeneic stem cell transplant recipients receiving KIR3DS1+ donor cells demonstrated reduced risk of severe human adenovirus disease and faster viral clearance compared to KIR3DS1- recipients 2. KIR3DS1 expression is maintained during viral infection and can be induced on resting NK cells through stimulation 5. The receptor's expression is associated with reduced HIV-1 viral load and modulation of immune responses in tuberculosis and co-infections 6. These findings establish KIR3DS1 as a critical component of anti-viral NK cell immunity with potential therapeutic applications.